Teeft.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Teeft.i » - entrée « Influenza vaccine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Influenza vaccinations < Influenza vaccine < Influenza vaccine distribution  Facettes :

List of bibliographic references indexed by Influenza vaccine

Number of relevant bibliographic references: 72.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
001B65 (1997) Philip J. H. Sizer [Royaume-Uni]Towards an oral influenza vaccine
001B80 (1997) Edwin D. Kilbourne [États-Unis]In pursuit of influenza: Fort monmouth to valhalla (and back)
001B94 (1997) J. S. Ellis [Royaume-Uni] ; C. J. Sadler [Royaume-Uni] ; P. Laidler [Royaume-Uni] ; H. Rebelo De Andrade [Portugal] ; M. C. Zambon [Royaume-Uni]Analysis of influenza A H3N2 strains isolated in England during 1995–1996 using polymerase chain reaction restriction
001C06 (1996) Yoshio Hirota [Japon] ; Masaro Kaji [Japon] ; Saburo Ide [Japon] ; Shuro Goto [Japon] ; Tetsuya Oka [Japon]The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age
001C08 (1996) Raphael Levi [Israël] ; Ruth Arnon [Israël]Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection
001C64 (1996) R. Morgan [Royaume-Uni] ; D. King [Royaume-Uni]Influenza vaccination in the elderly.
001C70 (1996) Xiyan Xu ; Nancy J. Cox ; Catherine A. Bender ; Helen L. Regnery ; Michael W. ShawGenetic Variation in Neuraminidase Genes of Influenza A (H3N2) Viruses
001D04 (1995) Takashi Tomoda [États-Unis] ; Hideo Morita [États-Unis] ; Takanobu Kurashige [États-Unis] ; Hunein F. Maassab [États-Unis]Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response
001D14 (1995) Z. Moldoveanu [États-Unis] ; M. L. Clements [États-Unis] ; S. J. Prince [États-Unis] ; B. R. Murphy [États-Unis] ; J. Mestecky [États-Unis]Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
001D79 (1994) John J. Treanor [États-Unis]Viral infections of the respiratory tract: prevention and treatment
001E01 (1994) Takayuki Nagai [Japon] ; Haruki Yamada [Japon]In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine “Sho-seiryu-to” and its mode of action
001E03 (1994) Shin-Ichi Tamura [Japon] ; Hideki Asanuma [Japon] ; Yuji Ito [Japon] ; Keiko Yoshizawa [Japon] ; Takashi Nagamine [Japon] ; Chikara Aizawa [Japon] ; Takeshi Kurata [Japon]Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice
001E24 (1994) K. Scheepers [Allemagne] ; H. Becht [Allemagne]Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes
001E32 (1994) Youri Ghendon [Suisse]Introduction to pandemic influenza through history
001E33 (1994) Martin WiselkaInfluenza: diagnosis, management, and prophylaxis
001E41 (1994) Harumi Kuno-Sakai [Japon] ; Mikio Kimura [Japon] ; Kazuyo Ohta [Japon] ; Rumi Shimojima [Japon] ; Yasumasa Oh [Japon] ; Hideo Fukumi [Japon]Developments in mucosal influenza virus vaccines
001E43 (1994) C. W. Potter [Royaume-Uni]Attenuated influenza virus vaccines
001E60 (1993) R. Pyh L [Finlande] ; L. Kinnunen [Finlande] ; V. Kumpulainen [Finlande] ; N. Ikonen [Finlande] ; M. Kleemola [Finlande] ; K. Cantell [Finlande]Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift
001E65 (1993) Pedro A. Piedra [États-Unis] ; W. Paul Glezen [États-Unis] ; Innocent Mbawuike [États-Unis] ; William C. Gruber [États-Unis] ; Barbara D. Baxter [États-Unis] ; F. James Boland [États-Unis] ; Richard W. Byrd [États-Unis] ; Lawrence L. Fan [États-Unis] ; Jessica K. Lewis [États-Unis] ; Linda J. Rhodes [États-Unis] ; Stephen E. Whitney [États-Unis] ; Larry H. Taber [États-Unis]Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children
001F13 (1993) J. S. Robertson [Royaume-Uni]Clinical influenza virus and the embryonated Hen's egg
001F34 (1992) Juan Mcewen [Israël] ; Raphael Levi [Israël] ; Robert J. Horwitz [Israël] ; Ruth Arnon [Israël]Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Influenza vaccine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Influenza vaccine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Influenza vaccine
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021